
ACM Derma Novophane Hair & Nail Supplement, Strengthens & Promotes Growth, 60 Capsules
60 capsules
About this product
Novophane capsules by ACM are a specialized dietary supplement designed to enhance the health and vitality of your hair and nails. These capsules work from within to nourish hair follicles and strengthen nail structure.
- Fortified with Biotin and Zinc to support robust hair and nail health.
- Helps reduce hair loss and brittle nails, promoting stronger growth.
- Contributes to healthy hair vitality and enhances nail strength and appearance.
- Supports cell regeneration and immune function with its essential nutrient blend.
How to use
How to Use:
- Take two capsules daily with a meal, or as directed by your physician or pharmacist.
- It is recommended to take with food to minimize the possibility of gastrointestinal upset.
- For optimal results, consistent and continuous use is advised.
Warnings: Do not exceed the recommended dosage. Consult your doctor before use if you are pregnant, nursing, or have specific medical conditions. Biotin may interfere with certain laboratory tests.
Frequently asked questions
What are Novophane Hair and Nail Capsules?
Novophane capsules by ACM are a dietary supplement containing biotin, zinc, and other essential nutrients to support hair and nail health, helping to reduce loss and breakage.
What are the benefits of using Novophane?
These capsules help strengthen hair and nails, promote healthy growth, improve their appearance, and reduce issues like hair loss and brittle nails. They also contribute to immune function.
How do I use Novophane capsules?
It is recommended to take two capsules daily with meals. For best results, continue regular use or as advised by your healthcare provider.
Are there any side effects of Novophane capsules?
Generally, the capsules are well-tolerated. Mild gastrointestinal upset may occur. Very high doses of zinc can lead to copper deficiency, and biotin may interfere with certain lab tests.
Related products
Customer reviews
Reviews
No reviews yet



